Main Story

Editor’s Picks

Trending Story

Jyong Biotech has updated its market entry strategy for innovative botanical pharmaceuticals, establishing multiple competitive advantages for its new drug portfolio

Jyong Biotech Ltd. (Nasdaq stock code: MENS) (hereinafter referred to as “the Company” or “Jyong Biotech”) is a science-driven biotechnology...